Verismo Therapeutics is building out an R&D facility at an expanded CIC Philly

It’s been a year of growth for a clinical-stage biotech company Verismo Therapeutics. Based in University…

Tango Therapeutics: Behind The Recent Momentum (NASDAQ:TNGX)

wacomka And those seen dancing were thought insane by those who couldn’t hear the music.”- Friedrich…

Transforming bacterial cells into living artificial neural circuits; applications include biomanufacturing and therapeutics — ScienceDaily

Technion and MIT scientists brought together concepts from electrical engineering and bioengineering tools to create cells…

Carisma Therapeutics Announces Clinical & Pre-Clinical Updates | DNA RNA and Cells

Carisma Therapeutics announces clinical and pre-clinical updates details Category: DNA RNA and Cells Published on Saturday,…

GT Biopharma Presents Two Posters at the Society for Immunotherapy of Cancer’s 37th Annual Meeting

GT Biopharma Inc. (the “Company” or “GTB”) (NASDAQ: GTBP), a clinical-stage immuno-oncology company focused on the…

TANGO THERAPEUTICS, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)

The following discussion and analysis of our financial condition and results of operations should be read…

Hubro Therapeutics AS acquires GM-CSF vaccine adjuvant from Targovax ASA in asset purchase agreement

· Hubro acquires the GM-CSF project from Targovax for a cash payment of NOK10m · Hubro…

TCR-2 Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T-cell…

TCR-2 THERAPEUTICS PRESENTS PRECLINICAL DATA ON FUNCTIONAL ACTIVITY OF GAVO-CEL AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER

TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T-cell…

TCR2 Therapeutics (TCRR) Presents Preclinical Data on Functional Activity of Gavo-cel

Join us on Wall Street StreetInsider Premium. Request your 1-week free trial here. TCR2 Therapeutics Inc.…

Cancer Therapeutics Market Expected to Reach $180,193 Million,

Cancer Drugs Market The cancer therapeutics market size was estimated at US$98,900 million in 2018 and…

Cancer Therapeutics Market value is set to grow by USD 238.2

The latest study offered by Acumen Research and Consulting focuses on the size, market share, growth…